Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
New data from a clinical trial of Alzheimer's Disease using a drug called Nilvadipine identified by researchers at the Roskamp Institute show that...
The Roskamp Institute is pleased to announce that its third-annual signature event, Grey Matters—A Symposium on Alzheimer's Disease Research, is half ...
The Roskamp Institute is pleased to announce that its second annual seminar, Grey Matters—A Symposium on Alzheimer's Disease Research, is nearly sold ...
Los científicos del Roskamp Institute (www.rfdn.org), una instalación de investigación biomédica sin ánimo de lucro especializada en estudiar la...
Des chercheurs du Roskamp Institute (www.rfdn.org), un centre de recherche biomédicale sans but lucratif spécialisé dans la recherche sur la maladie...
Wissenschaftler des Roskamp Institute (www.rfdn.org), einer gemeinnützigen biomedizinischen Forschungseinrichtung, die sich auf die Erforschung von...
Scientists at the Roskamp Institute (www.rfdn.org), a not-for-profit biomedical research facility specializing in Alzheimer's disease research, have...
Today the Roskamp Institute said that it is pleased to announce that it will soon begin clinical trials of RCP-006, a compound found in tobacco, for...
Scientists at the Roskamp Institute in Sarasota, Florida, have shown that mice that naturally develop Alzheimer's are able to ward off the growth of...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.